University of Essex, FRCPsych, Consultant Psychiatrist East London NHS Foundation Trust, UK.
J Affect Disord. 2013 Oct;151(1):85-91. doi: 10.1016/j.jad.2013.05.056. Epub 2013 Jun 14.
Chronic major depressive disorder and dysthymia are associated with a high burden and substantial care costs. New and more effective treatments are required. This is the first randomized controlled trial designed to evaluate the effectiveness of Body Psychotherapy (BPT) in patients with chronic depression.
Patients with chronic depressive syndromes (more than 2 years symptomatic) and a total score of ≥ 20 on the Hamilton Rating Scale for Depression (HAMD) were randomly allocated to either immediate BPT or a waiting group which received BPT 12 weeks later. BPT was manualized, delivered in small groups in 20 sessions over a 10 weeks period, and provided in addition to treatment as usual. In an intention to treat analysis, primary outcome were depressive symptoms at the end of treatment adjusted for baseline symptom levels. Secondary outcomes were self-esteem and subjective quality of life.
Thirty-one patients were included and twenty-one received the intervention. At the end of treatment patients in the immediate BPT group had significantly lower depressive symptom scores than the waiting group (mean difference 8.7, 95% confidence interval 1.0-16.7). Secondary outcomes did not show statistically significant differences. When the scores of the waiting group before and after BPT (as offered after the waiting period) were also considered in the analysis, the differences with the initial waiting group remained significant.
The results suggest that BPT may be an effective treatment option for patients with chronic depression. Difficulty recruiting and subsequent attrition was one of the limitations, but the findings merit further trials with larger samples and process studies to identify the precise therapeutic mechanisms.
慢性重度抑郁症和心境恶劣障碍与高负担和大量的医疗成本有关。需要新的、更有效的治疗方法。这是第一个旨在评估身体心理疗法(BPT)对慢性抑郁症患者有效性的随机对照试验。
患有慢性抑郁综合征(症状持续超过 2 年)且汉密尔顿抑郁评定量表(HAMD)总分≥20 分的患者被随机分配到立即接受 BPT 或等待组,后者在 12 周后接受 BPT。BPT 是标准化的,在 10 周内通过 20 次小团体治疗进行,除了常规治疗外还提供 BPT。在意向治疗分析中,主要结局是调整基线症状水平后的治疗结束时的抑郁症状。次要结局是自尊和主观生活质量。
共纳入 31 例患者,其中 21 例接受了干预。治疗结束时,立即接受 BPT 的患者的抑郁症状评分明显低于等待组(平均差异 8.7,95%置信区间 1.0-16.7)。次要结局没有显示出统计学上的显著差异。当等待组在接受 BPT 前后(作为等待期后提供的治疗)的评分也在分析中考虑时,与初始等待组的差异仍然显著。
结果表明,BPT 可能是慢性抑郁症患者的有效治疗选择。招募困难和随后的脱落是其中的一个限制因素,但这些发现值得进一步的临床试验,以确定确切的治疗机制,样本量更大且有过程研究。